FLUARIX
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
A/CALIFORNIA/7/2009 (H1N1) 15 MCG / 0.5 ML; A/VICTORIA/361/2011 (H3N2) 15 MCG / 0.5 ML
Available from:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC code:
J07BB03
Pharmaceutical form:
SUSPENSION FOR INJECTION
Administration route:
S.C, I.M
Manufactured by:
GLAXO SMITHKLINE BIOLOGICALS, GERMANY
Therapeutic group:
INFLUENZA, LIVE ATTENUATED
Therapeutic indications:
Prophylaxis of influenza, especially those who run an increased risk of associated complications. Fluarix is indicated in adults and children from 6 months of age.
Authorization date:
2011-05-01
